Regeneron, Bluebird ink anticancer cell therapy pact

Regeneron and Bluebird bio have teamed up to develop anticancer cell therapies. The collaboration combines Regeneron’s antibody expertise with Bluebird’s cell therapy toolkit in a bid to expand the list of tumors modified T cells can treat. To start … (본문 전체 8/6/2018 10:05 PM)